These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28937877)

  • 1. Changes in Peripapillary Nerve Fiber Layer Thickness after Adjuvant Stereotactic Radiotherapy in Patients with Neovascular Age-Related Macular Degeneration.
    Ranjbar M; Kurz M; Holzhey A; Rades D; Grisanti S
    Curr Eye Res; 2017 Dec; 42(12):1698-1706. PubMed ID: 28937877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EFFECT OF INTRAVITREAL RANIBIZUMAB ON GANGLION CELL COMPLEX AND PERIPAPILLARY RETINAL NERVE FIBER LAYER IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION USING SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY.
    Zucchiatti I; Cicinelli MV; Parodi MB; Pierro L; Gagliardi M; Accardo A; Bandello F
    Retina; 2017 Jul; 37(7):1314-1319. PubMed ID: 28574419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal nerve fiber layer thickness in patients receiving chronic anti-vascular endothelial growth factor therapy.
    Horsley MB; Mandava N; Maycotte MA; Kahook MY
    Am J Ophthalmol; 2010 Oct; 150(4):558-561.e1. PubMed ID: 20643396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripapillary RNFL thickness in nonexudative versus chronically treated exudative age-related macular degeneration.
    Yau GL; Campbell RJ; Li C; Sharma S
    Can J Ophthalmol; 2015 Oct; 50(5):345-9. PubMed ID: 26455968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal Ganglion Cell Layer Change in Patients Treated With Anti-Vascular Endothelial Growth Factor for Neovascular Age-related Macular Degeneration.
    Beck M; Munk MR; Ebneter A; Wolf S; Zinkernagel MS
    Am J Ophthalmol; 2016 Jul; 167():10-7. PubMed ID: 27084000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world experience of using stereotactic radiotherapy combined with anti-vascular endothelial growth factor to treat neovascular AMD.
    Creer R; Boonarpha N; Gould G; Rajai A; Chhabra R
    Graefes Arch Clin Exp Ophthalmol; 2024 Aug; 262(8):2411-2419. PubMed ID: 38446199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Vascular Endothelial Growth Factor Intravitreal Therapy and Macular Ganglion Cell Layer Thickness in Patients with Neovascular Age-Related Macular Degeneration.
    Abdolrahimzadeh S; Gharbiya M; Formisano M; Bertini F; Cerini A; Pacella E
    Curr Eye Res; 2019 Sep; 44(9):1000-1005. PubMed ID: 30999772
    [No Abstract]   [Full Text] [Related]  

  • 8. Subfoveal Choroidal Thickness as a Potential Predictor of Clinical Response to Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration.
    Ranjbar M; Kurz M; Holzhey A; Rades D; Grisanti S
    Ophthalmic Surg Lasers Imaging Retina; 2018 May; 49(5):320-328. PubMed ID: 29772042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate effect of anti-VEGF injections on optic nerve head: Correlation between intraocular pressure and anatomical peripapillary changes.
    Viggiano P; Buonamassa R; Grassi MO; Boscia G; Borrelli E; Landini L; Evangelista F; Malerba MG; Alessio G; Boscia F
    Eur J Ophthalmol; 2024 Jul; 34(4):1174-1182. PubMed ID: 37899575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: a prospective study.
    Soheilian M; Karimi S; Montahae T; Nikkhah H; Mosavi SA
    Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1705-1712. PubMed ID: 28616715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Changes in Retinal Nerve Fiber Layer Thickness after Intravitreal Anti-vascular Endothelial Growth Factor Therapy.
    Jo YJ; Kim WJ; Shin IH; Kim JY
    Korean J Ophthalmol; 2016 Apr; 30(2):114-20. PubMed ID: 27051259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of multiple injections of ranibizumab on retinal nerve fiber layer thickness in patients with age-related macular degeneration.
    Demirel S; Batioğlu F; Özmert E; Erenler F
    Curr Eye Res; 2015 Jan; 40(1):87-92. PubMed ID: 24871814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inner retinal layer change in glaucoma patients receiving anti-VEGF for neovascular age related macular degeneration.
    Saleh R; Karpe A; Zinkernagel MS; Munk MR
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):817-824. PubMed ID: 28127658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effect of intravitreal ranibizumab therapy on retinal nerve fiber layer in eyes with exudative age-related macular degeneration.
    Valverde-Megías A; Ruiz-Calvo A; Murciano-Cespedosa A; Hernández-Ruiz S; Martínez-de-la-Casa JM; García-Feijoo J
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1459-1466. PubMed ID: 31053943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the Ganglion Cell-inner Plexiform Layer after Consecutive Intravitreal Injections of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration Patients.
    Kim SY; Yoon MH; Chin HS
    Korean J Ophthalmol; 2020 Feb; 34(1):11-18. PubMed ID: 32037745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal Nerve Fiber Loss in Anti-VEGF Therapy for Age-Related Macular Degeneration Can Be Decreased by Anterior Chamber Paracentesis.
    Enders P; Sitnilska V; Altay L; Schaub F; Muether PS; Fauser S
    Ophthalmologica; 2017; 237(2):111-118. PubMed ID: 28245446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate of Macular Ganglion Cell-inner Plexiform Layer Thinning in Glaucomatous Eyes With Vascular Endothelial Growth Factor Inhibition.
    Lee WJ; Kim YK; Kim YW; Jeoung JW; Kim SH; Heo JW; Yu HG; Park KH
    J Glaucoma; 2017 Nov; 26(11):980-986. PubMed ID: 28930884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-Response Relationship between Intravitreal Injections and Retinal Nerve Fiber Layer Thinning in Age-Related Macular Degeneration.
    Wang L; Swaminathan SS; Yang J; Barikian A; Shi Y; Shen M; Jiang X; Feuer W; Gregori G; Rosenfeld PJ
    Ophthalmol Retina; 2021 Jul; 5(7):648-654. PubMed ID: 33045458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Lee H; Ji B; Chung H; Kim HC
    Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB
    Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.